MASS icon

908 Devices

4.58 USD
At close May 16, 4:00 PM EDT
After hours
4.61
+0.03
0.66%
1 day
0.00%
5 days
0.00%
1 month
0.00%
3 months
0.00%
6 months
0.00%
Year to date
0.00%
1 year
0.00%
5 years
-90.65%
10 years
-90.65%
 

About: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Employees: 246

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

45% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

5.61% less ownership

Funds ownership: 53.73% [Q3] → 48.12% (-5.61%) [Q4]

6% less funds holding

Funds holding: 86 [Q3] → 81 (-5) [Q4]

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

43% less capital invested

Capital invested by funds: $64.8M [Q3] → $36.9M (-$27.9M) [Q4]

97% less call options, than puts

Call options by funds: $2K | Put options by funds: $66K

Research analyst outlook

We haven’t received any recent analyst ratings for MASS.

Financial journalist opinion

Based on 8 articles about MASS published over the past 30 days

Neutral
Seeking Alpha
3 days ago
908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
908 Devices Inc. (NASDAQ:MASS ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Griffith - Chief Financial Officer Conference Call Participants Matt Larew - William Blair Dan Arias - Stifel Puneet Souda - Leerink Partners Brendan Smith - TD Cowen Operator Hello and welcome everyone to the 908 Devices First Quarter 2025 Financial Results Conference Call. My name is Becky [ph] and I'll be your operator today.
908 Devices Inc. (MASS) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
4 days ago
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
It is imperative to build a portfolio of low-beta stocks in a volatile market. Bridgewater Bancshares, Stride, 908 Devices, and Philip Morris are well-positioned to gain.
Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce
Negative
Zacks Investment Research
4 days ago
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
908 Devices Inc. (MASS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.33 per share a year ago.
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
Neutral
Business Wire
4 days ago
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS) a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2025. “We are off to a strong start in 2025, with first-quarter revenue exceeding our expectations and the transformation to 908 Devices 2.0 already delivering both top-line growth and meaningful cost reductions,” said Kevin J. Kno.
908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Negative
Zacks Investment Research
1 week ago
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Neutral
Business Wire
2 weeks ago
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announced that its devices for rapid chemical detection at the point of need are being included in strategic stockpiles within Europe as part of rescEU, an EU-funded project that is establishing a reserve of disaster response capabilities. These reserves include stockpiles of chemical, biological, radiation and nuclear (CBRN) capabilities for detection, sampling, identifi.
908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection
Positive
Zacks Investment Research
3 weeks ago
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, & Contango are well-poised to gain.
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
Neutral
Business Wire
3 weeks ago
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation
BOSTON--(BUSINESS WIRE)-- #chemicalID--908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld devices for chemical analysis, announces a $2M order from the Texas Department of Public Safety for its MX908 handheld mass spectrometry device. This investment in advanced tools for drug detection builds on an initial order placed last year for several MX908 devices, and is funded through the Community Oriented Policing Services (COPS) grant, a federally funded, state-administered program. The MX908 p.
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation
Negative
Zacks Investment Research
1 month ago
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
The tech-focused Nasdaq officially entered bear market territory on Friday, falling over 20% from its December peak.
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
Positive
Zacks Investment Research
1 month ago
New Strong Buy Stocks for April 1st
AFRM, TKOMY, FOLD, MASS and VFC have been added to the Zacks Rank #1 (Strong Buy) List on April 1, 2025.
New Strong Buy Stocks for April 1st
Charts implemented using Lightweight Charts™